Ipca Laboratories Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 2,136.66 | 1,844.23 | 1,863 |
| Operating Expense | 1,541.60 | 1,413.59 | 1,367.70 |
| Net Profit | 373.29 | 262.29 | 303.45 |
| Net Profit Margin | 17.47% | 14.22% | 16.29% |
| Earning Per Share | 14.71 | 11.54 | 11.96 |
| EBIDTA | 583.06 | 437.19 | 492.36 |
| Effective Tax Rate | 21.87% | 21.85% | 22.38% |
Particulars
Jun 2026
Revenue2,136.66
Operating Expense1,541.60
Net Profit373.29
Net Profit Margin17.47
Earning Per Share14.71
EBIDTA583.06
Effective Tax Rate21.87
